Beta Drugs Limited raises INR 117 cr from HealthQuad, Inti Capital and others to accelerate growth plans

Beta Drugs Limited raises INR 117 crore from HealthQuad, Inti Capital, and others through a preferential allotment of convertible debentures and equity shares. This investment will aid Beta Drugs in accelerating its growth plans and expanding its footprint globally, with a goal to be among India’s top five oncology companies.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *